Investors seeking the next obesity-like market opportunity will be closely watching developments related to treatments for Alzheimer’s disease in 2025.
The risk of developing dementia may be double what was previously thought. But there are things the U.S. can do to help fight ...
LEXINGTON Researchers at the University of Kentucky’s Sanders-Brown Center on Aging are at the forefront of advancing ...
Hosted on MSN23h
FDA beats EMA to most approved new drugs in 2024On 15 January, the two agencies released respective lists of medicines approved last year. The FDA approved 50 novel drugs ...
And only a fraction of patients have their hypertension well-controlled, meaning there’s a need for novel strategies. The ...
Zacks.com on MSN22h
Pharma Stock Roundup: J&J's ITCI Buyout, LLY's Weak Q4 SalesKey Takeaways JNJ will buy Intra-Cellular Therapies, producer of a drug for bipolar disorder, for $14.6 billion. Eli Lilly ...
These can start a process in the brain where the substances that cause Alzheimer’s disease build up around the injured area. Wear protective headgear in situations where there is a higher-than-normal ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback